The carnitine transporter OCTN2 (SLC22A5), required for cellular uptake of carnitine, has been identified in a susceptibility locus for IBD [3], and the susceptibility variant has been associated with decreased levels of SLC22A5 transcripts in Crohn’s disease [26]. Here, SLC22A5 is linked to Crohn disease.